Additional Equity infusion in Thyrocare Laboratories (Tanzania) Limited – Joint Venture
Investor/Analyst Meeting
Intimation about the following analyst meetings to be held at our corporate office: i) Meeting of the representative(s) of Ambit
Investor/Analyst Meeting
Intimation that the representative(s) of SAIF Partners would be having a meeting with us at 1.00 P.M. on Friday, February 15,
Investor/Analyst Meeting
Intimation that the representatives of Kayne Anderson Rudnick Investment Management LLC, USA and Macquarie Capital Securities (India) Private Limited, would
Investor/Analyst Meeting
Intimation that representative(s) of SPARX Asset Management, would be having a one-to-one meeting with us at 2.30 P.M. on Tuesday,
Post-Result Conference Call
Intimation about conference call for Indian and Overseas Investors to be held on 12-02-2019 to discuss about Unaudited financial results
Board Meeting-Outcome
Intimation about the outcome of the Board Meeting held on 09-02-2019 – Approval of unaudited financial results for the quarter
Investor/Analyst Meeting
Intimation that Dr. A. Velumani, Chairman, Managing Director & CEO, would be participating at ‘10th Eureka Conference- London’ organized by M/s. Motilal Oswal
Investor/Analyst Meeting
Intimation that Dr. A. Velumani, Chairman & Managing Director, would be participating at ‘10th Enterprising India Investors’ Conference organized by
Board Meeting
Intimation about Board Meeting scheduled to be held on February 09, 2019 to inter alia, consider and approve the unaudited
Investor/Analyst Meeting
Intimation that a team of Fund Managers and Research Analysts of Malabar Investments would be having a meeting with Dr.